JOHN MARTIN DOCHERTY - 01 Sep 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
President, Director
Signature
/John Docherty/
Issuer symbol
LEXX
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 13:49:07 UTC
Previous filing
09 Jun 2021
Next filing
29 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 54,075 01 Sep 2021 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +15,000 +30% $0.000000 64,668 01 Sep 2021 Common Shares 15,000 $6.23 Direct
holding LEXX Stock Options 13,334 01 Sep 2021 Common Shares 13,334 $9.60 Direct
holding LEXX Stock Options 31,334 01 Sep 2021 Common Shares 18,000 $5.31 Direct
holding LEXX Stock Options 49,668 01 Sep 2021 Common Shares 18,334 $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.